These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17219423)

  • 21. Lack of association between genetic polymorphisms in cytokine genes and disease expression in patients with hereditary non-polyposis colorectal cancer.
    Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Scand J Gastroenterol; 2007 May; 42(5):628-32. PubMed ID: 17454884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC).
    Xicola RM; Bontu S; Doyle BJ; Rawson J; Garre P; Lee E; de la Hoya M; Bessa X; Clofent J; Bujanda L; Balaguer F; Castellví-Bel S; Alenda C; Jover R; Ruiz-Ponte C; Syngal S; Andreu M; Carracedo A; Castells A; Newcomb PA; Lindor N; Potter JD; Baron JA; Ellis NA; Caldes T; LLor X
    Carcinogenesis; 2016 Aug; 37(8):751-8. PubMed ID: 27234654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microsatellite instability in early onset and familial colorectal cancer.
    Brassett C; Joyce JA; Froggatt NJ; Williams G; Furniss D; Walsh S; Miller R; Evans DG; Maher ER
    J Med Genet; 1996 Dec; 33(12):981-5. PubMed ID: 9004127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features and hMSH2/hMLH1 germ-line mutations in Chinese patients with hereditary nonpolyposis colorectal cancer.
    Shen XS; Zhao B; Wang ZJ
    Chin Med J (Engl); 2008 Jul; 121(14):1265-8. PubMed ID: 18713544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Four novel germline mutations in the MLH1 and PMS2 mismatch repair genes in patients with hereditary nonpolyposis colorectal cancer.
    Montazer Haghighi M; Radpour R; Aghajani K; Zali N; Molaei M; Zali MR
    Int J Colorectal Dis; 2009 Aug; 24(8):885-93. PubMed ID: 19479271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome.
    Risinger JI; Barrett JC; Watson P; Lynch HT; Boyd J
    Cancer; 1996 May; 77(9):1836-43. PubMed ID: 8646682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
    Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
    J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CHEK2 mutations and HNPCC-related colorectal cancer.
    Suchy J; Cybulski C; Wokołorczyk D; Oszurek O; Górski B; Debniak T; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dziuba I; Gogacz M; Wiśniowski R; Wandzel P; Banaszkiewicz Z; Kurzawski G; Kładny J; Narod SA; Lubiński J
    Int J Cancer; 2010 Jun; 126(12):3005-9. PubMed ID: 19876921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer.
    Niessen RC; Berends MJ; Wu Y; Sijmons RH; Hollema H; Ligtenberg MJ; de Walle HE; de Vries EG; Karrenbeld A; Buys CH; van der Zee AG; Hofstra RM; Kleibeuker JH
    Gut; 2006 Dec; 55(12):1781-8. PubMed ID: 16636019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis.
    Park JG; Vasen HF; Park KJ; Peltomaki P; Ponz de Leon M; Rodriguez-Bigas MA; Lubinski J; Beck NE; Bisgaard ML; Miyaki M; Wijnen JT; Baba S; Lynch HT
    Dis Colon Rectum; 1999 Jun; 42(6):710-5; discussion 715-6. PubMed ID: 10378593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of germline hereditary non-polyposis colorectal cancer gene mutations in patients with multiple or early onset colorectal adenomas.
    Beck NE; Tomlinson IP; Homfray TF; Frayling IM; Hodgson SV; Bodmer WF
    Gut; 1997 Aug; 41(2):235-8. PubMed ID: 9301504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree.
    Wagner A; Hendriks Y; Meijers-Heijboer EJ; de Leeuw WJ; Morreau H; Hofstra R; Tops C; Bik E; Bröcker-Vriends AH; van Der Meer C; Lindhout D; Vasen HF; Breuning MH; Cornelisse CJ; van Krimpen C; Niermeijer MF; Zwinderman AH; Wijnen J; Fodde R
    J Med Genet; 2001 May; 38(5):318-22. PubMed ID: 11333868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features and mismatch repair gene mutation screening in Chinese patients with hereditary nonpolyposis colorectal carcinoma.
    Liu SR; Zhao B; Wang ZJ; Wan YL; Huang YT
    World J Gastroenterol; 2004 Sep; 10(18):2647-51. PubMed ID: 15309712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer.
    Akiyama Y; Iwanaga R; Saitoh K; Shiba K; Ushio K; Ikeda E; Iwama T; Nomizu T; Yuasa Y
    Gastroenterology; 1997 Jan; 112(1):33-9. PubMed ID: 8978340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer.
    Genuardi M; Anti M; Capozzi E; Leonardi F; Fornasarig M; Novella E; Bellacosa A; Valenti A; Gasbarrini GB; Roncucci L; Benatti P; Percesepe A; Ponz de Leòn M; Coco C; de Paoli A; Valentini M; Boiocchi M; Neri G; Viel A
    Int J Cancer; 1998 Mar; 75(6):835-9. PubMed ID: 9506527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preferential amplification of AURKA 91A (Ile31) in familial colorectal cancers.
    Hienonen T; Salovaara R; Mecklin JP; Järvinen H; Karhu A; Aaltonen LA
    Int J Cancer; 2006 Jan; 118(2):505-8. PubMed ID: 16049965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The -149C>T SNP within the DeltaDNMT3B gene, is not associated with early disease onset in hereditary non-polyposis colorectal cancer.
    Reeves SG; Mossman D; Meldrum CJ; Kurzawski G; Suchy J; Lubinski J; Scott RJ
    Cancer Lett; 2008 Jun; 265(1):39-44. PubMed ID: 18336997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.